about
Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-AnalysisThe altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transportersThe roles of CD147 and/or cyclophilin A in kidney diseasesCD147 expression in human gastric cancer is associated with tumor recurrence and prognosis.The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literatureFocal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.EMMPRIN promotes angiogenesis, proliferation, invasion and resistance to sunitinib in renal cell carcinoma, and its level predicts patient outcomePrognostic role of extracellular matrix metalloproteinase inducer/CD147 in gastrointestinal cancer: a meta-analysis of related studies.A novel role of EMMPRIN/CD147 in transformation of quiescent fibroblasts to cancer-associated fibroblasts by breast cancer cells.CD147 knockdown improves the antitumor efficacy of trastuzumab in HER2-positive breast cancer cellsRole of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects.CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis.Extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 overexpression is associated with loss of hormone receptor expression and poor prognosis in endometrial cancer.EMMPRIN/CD147 expression is associated with disease-free survival of patients with colorectal cancer.Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer.Overexpression of EMMPRIN is associated with lymph node metastasis and advanced stage of non-small cell lung cancer: a retrospective study.Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer.
P2860
Q26771312-3B29D772-5426-4D23-A40A-55D1DE97DD8BQ28072360-E48C1E00-E884-43EF-B2B8-F9074D91BF3EQ28083416-8794EF86-B30E-4A89-A884-9F9F5CB863CAQ33825595-2706894F-12EC-4CF8-9EC8-7EF473FE7B47Q34486547-A8F61C30-DF45-4AF7-BB2A-4964B67AAF1DQ34797092-B6326064-CF68-4FEB-A0B8-8793498BF547Q35000659-B3B0BAF4-9BAB-41EA-B366-7B39D0A6AB1CQ36170610-17308DD1-829B-4CC7-BE5D-E8167E0AC60DQ37589853-9ADA66A3-B63C-4C81-9599-60694D9F766AQ37628926-19B27A08-4A3E-4540-8260-9A4491409049Q38244309-51B6D0B9-1983-4AA2-92FF-6DEDE34FDF39Q38476060-6D03DB75-82A2-411F-B3C9-8E22D7BAD2BAQ38949683-E07D5EF5-D17F-40B4-8BC4-53DED5F72B8FQ41550079-9BD9CD41-C211-4D96-8FC7-2C5E99121FC1Q45386247-2A1E4075-A052-482E-BB3E-6F1D9B20E93AQ47100203-E4A8F33B-01CF-4250-BBE5-D0083E964B30Q47101394-EAFA259A-2F63-4CEA-A8D3-C2130018D2D2Q51026487-D74E04B7-4CEE-4791-8D59-3F82B80428CB
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Role of emmprin in endometrial cancer
@ast
Role of emmprin in endometrial cancer
@en
Role of emmprin in endometrial cancer
@nl
type
label
Role of emmprin in endometrial cancer
@ast
Role of emmprin in endometrial cancer
@en
Role of emmprin in endometrial cancer
@nl
prefLabel
Role of emmprin in endometrial cancer
@ast
Role of emmprin in endometrial cancer
@en
Role of emmprin in endometrial cancer
@nl
P2093
P2860
P356
P1433
P1476
Role of emmprin in endometrial cancer
@en
P2093
Atsushi Hongo
Junichi Kodama
Keiichiro Nakamura
Yuji Hiramatsu
P2860
P2888
P356
10.1186/1471-2407-12-191
P407
P577
2012-05-28T00:00:00Z
P5875
P6179
1021879665